ALDH7A1 and non-small cell lung carcinoma: All PDE inhibitors investigated in the study (PDE8i, PDE5i, PDE9i, and PDE10i) promoted cell growth in a dose-dependent manner across all evaluated NSCLC cell lines, except Ludlu1 (Figure S1, Table S2).